[Federal Register Volume 64, Number 143 (Tuesday, July 27, 1999)] [Corrections] [Page 40651] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: C9-18377] Federal Register / Vol. 64, No. 143 / Tuesday, July 27?, 1999 / Corrections [[Page 40651]] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Opportunity for Licensing: Vasostatin, an Inhibitor of Endothelial Cell Growth and Angiogenesis Correction In notice document 99-18377, appearing on page 38686, in the issue of Monday, July 19, 1999, make the following corrections: 1. The subject line should appear as set forth above. 2. In the first column, under SUMMARY, in the tenth line, ``at'' should read ``a''. [FR Doc. C9-18377 Filed 7-26-99; 8:45 am] BILLING CODE 1505-01-D
Document
Opportunity for Licensing: Vasostatin, an Inhibitor of Endothelial Cell Growth and Angiogenesis
[Federal Register Volume 64, Number 143 (Tuesday, July 27, 1999)] [Corrections] [Page 40651] From the Federal Register Online via the Government Publishing Office [ www.gpo.gov ...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
64 FR 40651
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“Opportunity for Licensing: Vasostatin, an Inhibitor of Endothelial Cell Growth and Angiogenesis,” thefederalregister.org (July 27, 1999), https://thefederalregister.org/documents/C9-18377/opportunity-for-licensing-vasostatin-an-inhibitor-of-endothelial-cell-growth-and-angiogenesis.